PCI Biotech: Invitation to Q4 2022 results presentation
Oslo, Norway, 13 February 2023 – PCI Biotech (OSE: PCIB) invites to an online presentation…
Year: 2023
Verizon customers make up 60% of Super Bowl LVII attendees
Game day data usage spikes 36% over 2022 NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE)…
ZOLEO Inc. and The Global Rescue Companies Announce Worldwide Partnership
Global Rescue to provide emergency coordination services to ZOLEO subscribers in Canada and the US,…
Cocodensado Introduces One-Stop Solution for Healthy Sweet Treats to Satisfy Sugar Cravings
Gilbert, Arizona–(Newsfile Corp. – February 13, 2023) – Cocodensado, an emerging leading provider of organic…
LBank Weekly Listing Report, 13th February 2023
Road Town, British Virgin Islands–(Newsfile Corp. – February 13, 2023) – As a world class…
Personas Announces Full Revocation of Cease Trade Order and Provides Update on Reinstatement of Trading on the TSXV
Toronto, Ontario–(Newsfile Corp. – February 13, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“)…
Easterly Asset Management Hires Joe Yasinski as Senior Vice President
BEVERLY, Mass.–(BUSINESS WIRE)–Easterly Asset Management (“Easterly”), a multi-affiliate asset manager of high-performing boutique investment firms,…
Trine University and MedCerts Collaboration Brings Certifications and College Credits to Students
Eligible individuals can earn in-demand healthcare certifications and credit toward a Trine University degree ANGOLA,…
Ultisim Issues An Open Letter to Mark Zuckerberg
CHAPEL HILL, North Carolina–(BUSINESS WIRE)–Ultisim issued an open letter to Mark Zuckerberg today with a…
Entera Bio to Participate in the SVB Securities Global Biopharma Conference
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Entera Bio to Participate in the SVB Securities Global Biopharma Conference
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology
TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV:…
NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology
TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV:…
Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause
Topline trial results expected mid-March 2023 NEWTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Acer…
Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause
Topline trial results expected mid-March 2023 NEWTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Acer…
Cerevance Expands Series B Financing with Additional $51 Million
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s…
Cerevance Expands Series B Financing with Additional $51 Million
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s…
Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a…
Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a…
Coherus Granted Permanent, Product-Specific Q-Code for CIMERLI® (ranibizumab-eqrn) from the Centers for Medicare and Medicaid Services
– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on…